Analysts Thursdays: Clear Street Senior Biotech Analyst Kaveri Pohlman shares her take on biotech for 2026 and discusses her top picks
- blonca9
- 2 days ago
- 1 min read
She discusses Arrivent Biopharma, Oruka Therapeutics, Jade Biosciences, Zura Bio, and Pavella Therapeutics.
Chapters
General take on biotech - 0:52
Arrivent BioPharma - 4:20
Oruka Therapeutics - 6:46
Jade Biosciences - 9:18
Zura Bio - 12:07
Other catalysts / Pavella - 16:02














.png)

